Home/Filings/4/0001193805-17-000276
4//SEC Filing

ADMA BIOLOGICS, INC. 4

Accession 0001193805-17-000276

$ADMACIK 0001368514operating

Filed

Feb 15, 7:00 PM ET

Accepted

Feb 16, 8:11 PM ET

Size

5.6 KB

Accession

0001193805-17-000276

Insider Transaction Report

Form 4
Period: 2017-02-14
Mond James
CSO/CMO
Transactions
  • Award

    Employee Stock Option (right to buy)

    2017-02-14+22,50022,500 total
    Exercise: $5.00Exp: 2027-02-14Common Stock (22,500 underlying)
Footnotes (1)
  • [F1]The option vests over a four year period with 25% of the shares of common stock underlying the option vesting on the one year anniversary of the grant date and the remaining 75% of the shares of common stock underlying the option vesting in equal monthly installments thereafter beginning on March 14, 2018, becoming fully vested on February 14, 2021.

Issuer

ADMA BIOLOGICS, INC.

CIK 0001368514

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001368514

Filing Metadata

Form type
4
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 8:11 PM ET
Size
5.6 KB